Sfoglia per AUTORE
FORNARO M
Collezione ASL Novara
Items : 5
Efficacy and safety of selegiline across different psychiatric disorders: A systematic review and meta-analysis of oral and transdermal formulations. in European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology / Eur Neuropsychopharmacol. 2023 Jul;72:60-78. doi: 10.1016/j.euroneuro.2023.03.012. Epub 2023 Apr 21.
2023
ASL Novara
ASL Novara
Rossano F; Caiazza C; Sobrino A; Solini N; Vellucci A; Zotti N; Fornaro M; Gillman K; Cattaneo CI; Van den Eynde V; Birkenhager TK; Ruhé HG; Stahl S; Iasevoli F; de Bartolomeis A;
The shocking attitude toward electroconvulsive therapy in Italy. in CNS spectrums / CNS Spectr. 2022 Apr;27(2):131-133. doi: 10.1017/S1092852920002059. Epub 2020 Dec 4.
2022
ASL Novara
ASL Novara
Cattaneo CI; Ressico F; Fornaro M; Fazzari G; Perugi G;
Commentary letter on "Revitalizing monoamine oxidase inhibitors: a call for action". in CNS spectrums / CNS Spectr. 2020 Aug;25(4):458-459. doi: 10.1017/S1092852919001378. Epub 2019 Oct 30.
2020
ASL Novara
ASL Novara
Cattaneo CI; Fornaro M; Ressico FV; Perugi G;
Brexpiprazole for treatment-resistant major depressive disorder. in Expert opinion on pharmacotherapy / Expert Opin Pharmacother. 2019 Nov;20(16):1925-1933. doi: 10.1080/14656566.2019.1654457. Epub 2019 A
2019
ASL Novara
ASL Novara
Fornaro M; Fusco A; Anastasia A; Cattaneo CI; De Berardis D;
Sudden valproate-induced hyperammonemia managed with L-carnitine in a medically healthy bipolar patient: Essential review of the literature and case report. in Medicine / Medicine (Baltimore). 2017 Sep;96(39):e8117. doi: 10.1097/MD.0000000000008117.
2017
ASL Novara
ASL Novara
Cattaneo CI; Ressico F; Valsesia R; D'Innella P; Ballabio M; Fornaro M;